Lymphoma and pregnancy.
Coincident lymphoma and pregnancy is rare, occurring in only one of 1,000 or fewer deliveries. Patients with Hodgkin's disease usually present with typical manifestations, and most studies suggest that the disease probably has little or no effect on the pregnancy and vise versa. In contrast, patients with non-Hodgkin's lymphoma often have unusual manifestations and their diagnosis is frequently delayed. These patients usually have aggressive, advanced-stage disease and a poor outcome. The optimal management of these women requires special considerations. Treatment during the first trimester is associated with significant risk to the developing fetus and should be avoided. Women requiring treatment at this time should have a therapeutic abortion. Beyond the first trimester, the management options for women with Hodgkin's disease include observation until disease progression or delivery, single-agent vinblastine, modified or standard combination chemotherapy, and radiation therapy (with appropriate shielding). Because of their poor prognosis, women with non-Hodgkin's lymphoma should receive standard chemotherapy (despite the potential risk to the developing fetus).
Pohlman
B
B
Taussig Cancer Center, and the Department of Radiation Oncology, Cleveland Clinic Foundation, OH 44195, USA.
Macklis
R M
RM
D005260:Female; D006801:Humans; D008223:Lymphoma / Q000453:epidemiology / Q000628:therapy; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000453:epidemiology / Q000628:therapy